Nasal spray prevents Covid-19 spread

Israeli biotech Nasus has developed the Taffix anti-viral nasal spray. It creates a thin gel over the nasal mucosa, blocking viruses for 4-5 hours. In recent tests, Taffix reduced Covid-19 infections from 10% down to 2.4%. Taffix is marketed in Europe and available at SuperPharm in Israel.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *